Literature DB >> 15736355

Transcatheter occlusion of the patent ductus arteriosus: a comparison of two devices.

M K El Mallah1, A J Sands, F A Casey, B G Craig, H C Mulholland.   

Abstract

BACKGROUND: Transcatheter occlusion of the arterial duct is a safe and effective alternative to surgical closure. The Rashkind umbrella occluder and the Cook coil are two established devices, although the former is no longer manufactured. AIMS: To assess any difference in outcomes between the use of the Cook detachable coil and the Rashkind double umbrella in patent ductus arteriosus (PDA) occlusion.
METHODS: A retrospective study of 77 patients in whom PDA occlusion was attempted using the Cook detachable PDA coil from March 1996 to March 2000. A comparison was carried out with patients in whom occlusion was attempted using the Rashkind double umbrella between 1989 and 1996.
RESULTS: The rate of immediate complete occlusion was 24% compared with 29.9% for the Rashkind device. The figure for complete occlusion after 24 hours with the PDA coil was 63% compared with 61.5% in the Rashkind group (p > 0.1). The overall closure rate in the coil group was 72% versus 74.6% for umbrellas.
CONCLUSION: The outcome in terms of complete duct closure using the Cook coil is comparable with figures obtained using the Rashkind umbrella. Both devices have a good safety profile in the short and medium-terms.

Entities:  

Mesh:

Year:  2002        PMID: 15736355     DOI: 10.1007/bf03170504

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  23 in total

1.  Follow-up after coil closure of patent ductus arteriosus.

Authors:  V S Goyal; M C Fulwani; R Ramakantan; H L Kulkarni; B V Dalvi
Journal:  Am J Cardiol       Date:  1999-02-01       Impact factor: 2.778

2.  Patent ductus arteriosus occlusion using detachable coils.

Authors:  R Bermúdez-Cañete; G Santoro; J Bialkowsky; I Herraiz; R Formigari; M Szkutnik; L Ballerini
Journal:  Am J Cardiol       Date:  1998-12-15       Impact factor: 2.778

3.  Effect of multiple coil closure of patent ductus arteriosus on blood flow to the left lung as determined by lung perfusion scans.

Authors:  J K Evangelista; Z M Hijazi; R L Geggel; E Oates; D R Fulton
Journal:  Am J Cardiol       Date:  1997-07-15       Impact factor: 2.778

4.  Residual and recurrent shunts after implantation of Cook detachable duct occlusion coils.

Authors:  O Uzun; D Dickinson; J Parsons; J L Gibbs
Journal:  Heart       Date:  1998-03       Impact factor: 5.994

5.  Transcatheter closure of patent ductus arteriosus with the use of Rashkind occluders and/or Gianturco coils: long-term follow-up in 123 patients and special reference to comparison, residual shunts, complications, and technique.

Authors:  S Janorkar; T Goh; J Wilkinson
Journal:  Am Heart J       Date:  1999-12       Impact factor: 4.749

Review 6.  Interventional cardiac catheterization advances in nonsurgical approaches to congenital heart disease.

Authors:  C G Cowley; T R Lloyd
Journal:  Curr Opin Pediatr       Date:  1999-10       Impact factor: 2.856

7.  Mechanical occlusion of the patent ductus arteriosus with Jackson coils.

Authors:  A El Sisi ; M Tofeig; R Arnold; I Peart; D J Kitchiner; F A Bu'Lock; K P Walsh
Journal:  Pediatr Cardiol       Date:  2001 Jan-Feb       Impact factor: 1.655

Review 8.  Eradicating acute hemolysis following transcatheter closure of ductus arteriosus by immediate deployment of a second device.

Authors:  L H Wang; J K Wang; C E Mullins
Journal:  Cathet Cardiovasc Diagn       Date:  1998-03

9.  Problems encountered during introduction of Gianturco coils for transcatheter occlusion of the patent arterial duct.

Authors:  O Galal; M de Moor; F Fadley; S Qureshi; S Naffa; S Oufi; M Suhl; F Abbag; A A Schmaltz
Journal:  Eur Heart J       Date:  1997-04       Impact factor: 29.983

10.  Haemolysis following implantation of duct occlusion coils.

Authors:  O Uzun; G R Veldtman; D F Dickinson; J M Parsons; M E Blackburn; J L Gibbs
Journal:  Heart       Date:  1999-02       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.